Joanne L. Viney - 13 Jun 2022 Form 4 Insider Report for Finch Therapeutics Group, Inc. (FNCH)

Role
Director
Signature
By: /s/ Joseph Vittiglio, Attorney-in-Fact
Issuer symbol
FNCH
Transactions as of
13 Jun 2022
Net transactions value
$0
Form type
4
Filing time
15 Jun 2022, 17:02:45 UTC
Previous filing
24 Jun 2021
Next filing
22 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FNCH Stock Option (right to buy) Award $0 +44,843 $0.000000 44,843 13 Jun 2022 Common Stock 44,843 $2.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest in twelve equal monthly installments beginning on July 13, 2022, subject to the Reporting Person continuing to provide service through each such date.